1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)Pediatric Growth Hormone Injectable Medication Precertification Request Aetna Precertification Notification 503 Sunport Lane Orlando FL 32809 Phone 1-866-503-0857 FAX 1-888-267-3277 Page 1 of 2 Please return Pages 1 and 2 for precertification of medications. Please indicate Start of treatment Start date / Continuation of therapy Date of lastVimizim®(elosulfase alfa) Medication Precertification Request. (All fields must be completed and legible for Precertification Review.) Aetna Precertification Notification Phone: 1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. Please indicate:1-866-503-0857 . For other lines of business: Please use other form . Note: Procrit and Epogen are non-preferred. The preferred products are Aranesp and Retacrit. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /(866) 841-8679. Negative (877) 308-1975. Negative (888) 641-3246. Show More. Frequently asked questions. What is a reverse phone lookup?Osteoporosis Injectable Medication. Recertification Request. Aetna Recertification Notification. 503 Support Lane, Orlando, FL 32809. Phone: 1-866 -503-0857 ...1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION - Required clinical information must be completed in its entirety for all precertification requests.1-866-503-0857. Or fax applicable request forms to . 1-888-267-3277. 9. Dorsal column (lumbar) neurostimulators: trial or implantation ... For the followingservices,providers call1-866-503-0857orfax applicable request forms to 1-888-267-3277,withthe following exceptions: • Forprecertificationof pharmacy -coveredspecialtydrugs(notedwith ...Phone: 1-866-503-0857 (TTY:711) VPRIV ® (velaglucerase alfa) FAX: 1-844-268-7263 . For other lines of business: Medication Precertification Request. Please use other form. Page 2 of 2 Note: Vpriv is non-preferred. The (All fields must be completed and legible for Precertification Review.) preferred products are Cerezyme and Elelyso. Patient ...Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.G. CLINICAL INFORMATION - Required clinical information must be completed for ALL precertification requests. For Initiation Requests (clinical documentation required for all requests): Note: Cimzia is non-preferred. Entyvio, Inflectra, Remicade, Simponi Aria, and unbranded infliximab are preferred for MA plans.1-866-752-7021 Injectable Precertification Request FAX: 1-888-267-3277 Page 4 of 4 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. ACKNOWLEDGEMENT Request Completed By1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...PHONE: 1-866-503-0857 . For other lines of business: Please use other form. Note: Darzalex Faspro is non-preferred. The preferred products are Bortezomib and Velcade. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatment160 Fountain Pkwy N. Suite 200. St. Petersburg, FL 33716-1205. Interested in ordering products from CCS? See how easy it is. Learn More. Contact CCS customer support via email at [email protected] or by phone at 1-888-MEDICAL. Hours of operation: 8:00a.m. - 6:00p.m. ET, Monday-Friday.Phone: 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 For Medicare Advantage Part B: Page 2 of 2 Phone: 1-866-503-0857 (All fields must be completed and legible for precertification review) FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. ACKNOWLEDGEMENT Request Completed ByPolicy: Precertification Criteria; Under some plans, including plans that use an open or closed formulary, Intravenous Immunoglobulins (IVIG) and Adagen are subject to Precertification. If Precertification requirements apply Aetna considers these medications to be medically necessary for those members who meet the following precertification criteria: (see also Appendix A)Reverse phone lookup for (866) 503-0857. Find full name, address, email, and photos for owner of (866) 503-0857 with Spokeo.1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /1-866-503-0857 (All fields must be completed and legible for precertification review) Fax: 1-888-267-3277. For Medicare Advantage Part B: Please Use Medicare Request Form . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)PHONE: 1-866-503-0857 . For other lines of business: Please use other form . Note: Trelstar is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatmentThe new Roku 4 has voice recognition, 4k, and something Apple doesn't: a remote control locator so you'll never need a replacement. By clicking "TRY IT", I agree to receive newslet...1-866-503-0857 For other lines of business: Please use other form. Note: Avsola is preferred for MA plans. Preferred status for MAPD plans varies based on indication. See section G. G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests. Continued on next pagePhone: 1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 For Medicare Advantage Part B: Page 2 of 2 Phone: 1-866-503-0857 (All fields must be completed and legible for precertification review) FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . H. ACKNOWLEDGEMENT Request Completed ByHomosexual people tend to experience more mental health problems than heterosexual people, research indicates. Homosexual people tend to experience more mental health problems than...Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Subject: Remicade. Drug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service ...For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. G. CLINICAL INFORMATION (continued) – – Required clinical information must be completed in its entirety for all precertification requests. Yes No Was the patient prescribed the requested drug due to clinical worsening after receiving gene replacement therapy (e.g ...1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA plans. On MAPD plans Entyvio is preferred for ulcerative colitis and non-preferred for Crohn’s disease. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / /PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Feraheme, Injectafer, and Monoferric are non-preferred. The preferred products are Ferrlecit (sodium ferric gluconate), Infed, and Venofer. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start dateDiabetic Testing Supplies Prior Authorization Request Form Ph: (866) 503-0857 Fax: (877) 269-9916 . MEMBER INFORMATION Member name . Member ID . Member Address, City, State, ZIPThis question is about Car Insurance @WalletHub • 12/09/20 This answer was first published on 12/10/20 and it was last updated on 12/09/20.For the most current information about a ...1-866-503-0857 . For other lines of business: Please use other form. Note: Abraxane and generic paclitaxel (protein bound) are non-preferred. The preferred products are docetaxel or paclitaxel. Docetaxel and paclitaxel do not require precertification. GR-69491-3 (1-23) Page 1 of 3 (All fields must be completed and legible for precertification ...Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Reactive Arthritis (Reiter’s syndrome) Yes . Was the treatment with methotrexate ineffective? Please indicate length of therapy: Less than 1 month . 1 month . 2 months . 3 months or greater . No . Yes1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 Page 2 of 2 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Subject: Remicade. Drug. Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service ...PHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Neupogen is non preferred. Zarxio is preferred. Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Eylea and Eylea HD are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.)Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all ...If you're watching movies, playing video games, or enjoying your favorite TV shows to just the speakers in your television, you're missing out. A great set of living room speakers ...Fulvestrant Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus Fulvestrant injection is used alone or in combination with ribociclib (Kisqali...Drug. Rituxan® (rituximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. For Oral Corticosteroid Clinical policy click here. Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit.Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277. For Oral Corticosteroid Clinical policy click hereIf it is medically necessary for a member to be treated initially with a medication subject to step therapy, the members treating physician may contact the Aetna Pharmacy Management Precertification Unit to request coverage as a medical exception at 1-866-503-0857. (See criteria under section II below). Medical Exception Criteria1-866-503-0857 . For other lines of business: Please use other form. Note: Ilumya is non-preferred. Preferred products may vary based on indication. See section G below. (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatmentAetna Precertification Notification Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment. Precertification...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 . For other lines of business: Please use other form. Note: Lanreotide (Cipla) is non-preferred. The preferred products are Sandostatin LAR and Page 1 of 2 Somatuline Depot. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment:Start date1-866-752-7021 . Medication Precertification Request . FAX: 1-888-267-3277 . Page 2 of 2 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued)1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for precertification review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 G. CLINICAL INFORMATION (continued)1-866-752-7021 Medication Precertification Request FAX: 1-888-267-3277 Page 2 of 2 For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOBFax this form to: 1-877-269-9916. For specialty drugs fax to: 1-888-267-3277. Aetna Specialty Pharmacy phone: 1-866-503-0857. OR. Submit your request onlinePHONE: 1-866-503-0857 . For other lines of business: Please use other form . Note: Trelstar is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date. Continuation of therapy, Date of last treatment1-866-503-0857 . For other lines of business: Please use other form. Note: Inflectra is non-preferred. Preferred products vary based on indication. See section G below. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / /Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Exception: Member's enrolled in an Individual Plan for the following pharmacy covered drugs - Actemra, Amevive, Cimzia, Cosentyx, Enbrel, Humira, Kineret, Orencia, Otezla, Simponi, Stelara, and Xeljanz please contact Aetna Pharmacy Management Precertification at 1-800-414-23861-866-752-7021 FAX: 1-888-267-3277 For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263 Patient First Name . Patient Last Name . Patient Phone . Patient DOB . G. CLINICAL INFORMATION (continued) - Required clinical information must be completed in its entirety for all precertification requests.Nonverbal communication is possible between culturally different people, but how? Learn about nonverbal communication in this article. Advertisement Let's say that you're traveling...Phone: 1-866-503-0857 (TTY: 711) FAX: 1-844-268-7263 For other lines of business: Please use other form. Note: Fylnetra, Nyvepria, Rolvedon, Stimufend, Udenyca and Udenyca Onbody are non-preferred. Fulphila and Neulasta/Neulasta Onpro are preferred. (All fields must be completed and legible for precertification review.) Patient First Name1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857. FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last treatment / / Precertification Requested By: Phone: Fax: A. PATIENT ...1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy: Date of last ...PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Eylea and Eylea HD are non-preferred. The preferred product is bevacizumab (Avastin). Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. (All fields must be completed and legible for precertification review.)Phone: 1-866-503-0857 (TTY:711) FAX: 1-844-268-7263 . For other lines of business: Please use other form . Note: Epogen, Jesduvroq and Retacrit are non-preferred. The preferred products are Aranesp and Procrit. Page 1 of 3 (All fields must be completed and legible for precertification review.) Please indicate:When request is initiated by a participating provider, and dialysis to be performed at a nonparticipating facility. Call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277. Dorsal column (lumbar) neurostimulators: trial or implantation. Electric or motorized wheelchairs and scooters.Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit. All criteria below must be met in order to obtain coverage of belimumab (Benlysta).. Precertification Criteria503 Sunport Lane, Orlando, FL 32809 . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review) Please indicate: Start of treatment: Start date: / / Continuation of therapy: Date of last treatment / /1-866-503-0857 . or fax applicable request forms to . 1-888-267-3277, with the following exceptions: • For precertification of pharmacy-covered specialtydrugs (noted with*) when memberis enrolled in a commercial plan, call . 1-855-240-0535 . or fax applicable request forms to . 1-877-269-9916 • Providers can use the drug-specificPrecertification of inclisiran (Leqvio) is required of all Aetna participating providers and members in applicable plan designs. For precertification of inclisiran (Leqvio), call (866) 752-7021 or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty Pharmacy Precertification.Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service for Remicade, see Utilization Management Policy on Site of Care for Specialty Drug Infusions at https://www.aetna ...Tremfya® (guselkumab) Medication Precertification Request. Page 2 of 2. (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263. PHONE: 1-866-503-0857. For other lines of business: Please use other form. Note: Tremfya is non-preferred.503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 Patient First Name Patient Last Name Patient Phone Patient DOB G. CLINICAL INFORMATION – Required clinical information must be completed in its entirety for all precertification requests.Exception: Requests for drugs administered by a healthcare professional that will be billed to the medical plan, call 1-866-503-0857 or fax applicable request forms to 1-888-267-3277. For Oral Corticosteroid Clinical policy click here1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA (All fields must be completed and legible for precertification review.) and MAPD plans. Please indicate: Start of treatment: Start date. Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax: A. PATIENT ...Phone: 1-866-752-7021 . FAX: ... Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for Precertification Review.) Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By:Phone: 1-866-503-0857. For other lines of business: Please use other form. Note: Zoladex is non-preferred. The preferred product is Eligard. Firmagon is also a preferred product. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / / Continuation of therapy, Date of last treatmentAetna Specialty Pharmacy phone: 1-866-503-0857 Aetna Member Number (claim cannot be processed without number) Group Number If you are enrolled in Medicare, check here Employee Name (First, Middle, Last) Employee Birthdate (MM/DD/YYYY) Employee Address (Street, City, State, ZIP Code) Company Name & Address (Street, City, State, ZIP Code)The form must be completed by the medical staff and submitted to Aetna in the proper state jurisdiction. Fax: 1 (877) 269-9916. Fax (Specialty Drugs): 1 (888) 267-3277. Aetna Specialty Pharmacy phone: 1 (866) 503-0857. All Aetna Forms.Right knee. Left knee. Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 both knees. If ASRx is dispensing, ship to: Dispensing Provider: Date of last treatment: Doctor’s office Patient Other: Aetna Specialty Pharmacy® or. Other: Phone: Fax:GR-68305-3 (9-23) MEDICARE FORM Immune Globulin (IG) Therapy Medication and/or Infusion Precertification Request Page 2 of 3 (All fields must be completed and legible for precertification review.)1-866-503-0857 (TTY: 711) For other lines of business: Please use other form. Note: Susvimo is non-preferred. The preferred products are bevacizumab (Avastin) first followed by Byooviz or Eylea/Eylea HD. Avastin (C9257) and bevacizumab biosimilars do not require precertification for ophthalmic use. Precertification Requested By:For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-844-268-7263. G. CLINICAL INFORMATION (continued) - - Required clinical information must be completed in its entirety for all precertification requests. Yes No Was the patient prescribed the requested drug due to clinical worsening after receiving gene replacement therapy (e.g ...Specialty Pharmacy Clinical Policy Bulletins. Aetna Non-Medicare Prescription Drug Plan. Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service for Remicade, see Utilization Management Policy on Site ...Precertification of sutimlimab-jome (Enjaymo) is required of all Aetna participating providers and members in applicable plan designs. For precertification of sutimlimab-jome (Enjaymo), call (866) 752-7021, or fax (888) 267-3277. For Statement of Medical Necessity (SMN) precertification forms, see Specialty Pharmacy Precertification .All you'll need is the 10-digit phone number in question, and you can find out who it belongs to, their location and even what type of phone it is. A reputable service like USPhoneBook.com pulls from billions of records to ensure you get the most up-to-date information available—and put a rest to those mystery numbers once and for all.Remicade® (infliximab) Note: Precertification review for these medications is handled through Aetna Specialty Precert Unit at 1-866-503-0857. Site of Care Utilization Management Policy applies. For information on site of service for Remicade, see Utilization Management Policy on Site of Care for Specialty Drug Infusions at https://www.aetna ...1-866-503-0857 . For other lines of business: Please use other form. Note: Entyvio is preferred on MA plans. On MAPD plans Entyvio is preferred for ulcerative colitis and non-preferred for Crohn's disease. (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / /Deal with 866 503 0857 on any platform with signNow Android or iOS apps and alleviate any document-based process today. The best way to change and eSign 866 503 0857 without breaking a sweat. Find 866 503 0857 and click Get Form to get started. Take advantage of the instruments we provide to complete your document.Phone: 1-866-503-0857 FAX: 1-844-268-7263 . Patient First Name . Patient Last Name . Patient Phone . Patient DOB . Reactive Arthritis (Reiter's syndrome) Yes . Was the treatment with methotrexate ineffective? Please indicate length of therapy: Less than 1 month . 1 month . 2 months . 3 months or greater . No . YesPrepare 866 503 0857 effortlessly on any device. Online document management has grown to be popular with businesses and individuals. It provides a perfect eco-friendly replacement for traditional printed and signed documents, as you can get the correct form and securely store it online.If it is medically necessary for a member to be treated initially with a medication subject to step therapy, the members treating physician may contact the Aetna Pharmacy Management Precertification Unit to request coverage as a medical exception at 1-866-503-0857. (See criteria under section II below). Medical Exception CriteriaPhone: 1-866-503-0857. FAX: 1-844-268-7263. Patient First Name. Patient Last Name. Patient Phone. Patient DOB. G. CLINICAL INFORMATION (continued) – Required clinical information must be completed in its entirety for all precertification requests.(denosumab) Injectable Medication Precertification Request Page 3 of 3 (All fields must be completed and legible for precertification review.) For Medicare Advantage Part B: FAX: 1-844-268-7263 PHONE: 1-866-503-0857 For other lines of business: Please use other form. Note: Xgeva is non-preferred. The preferred product is pamidronate or ...503 Sunport Lane, Orlando, FL 32809. Phone: 1-866-503-0857 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) FAX: 1-844-268-7263 Please indicate: Start of treatment: Start date . Continuation of therapy: Date of last treatment . Precertification Requested By: Phone: Fax:PHONE: 1-866-503-0857 (TTY: 711) For other lines of business: Please use other for, Medication Precertification Request . FAX: 1-888-267-3277. Page 1 of 2 For Medicare Advantage Part B: (All fields mu, 1-866-503-0857 . For other lines of business: Please use other form. Note: Xgeva is non-preferred. The , PHONE: 1-866-503-0857 . For other lines of business: Pleas, 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Pa, Radicava® (edaravone) Medication Precertification Req, 1-866-503-0857 . For other lines of business: Please use other form. Note: Xgeva is non-preferred. The , 1-866-503-0857 . For other lines of business: Please use, For Medicare Advantage Part B: Phone: 1-866-503-0857 FAX: 1-84, Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Me, 1-866-503-0857 (All fields must be completed and l, 866 503 0857. Get the up-to-date GR 68722 Medication Precerti, 1-866-752-7021 . Sandostatin, Sandostatin LAR Depot . FAX: 1-88, 1-866-503-0857. For other lines of business: Please use other form, Phone: 1-866-752-7021 FAX: 1-888-267-3277 For Medi, The best way to double-check that a number is a scammer is to type , Phone: 1-866-752-7021. Medication Precertification Req, Therefore, the airSlate SignNow web application is a must-ha.